Abstract:Abstract Motivation The diverse structures and functions inherent in RNAs present a wealth of potential drug targets. Some small molecules are anticipated to serve as leading compounds, providing guidance for the development of novel RNA-targeted therapeutics. Consequently, the determination of RNA-small molecule binding affinity is a critical undertaking in the landscape of RNA-targeted drug discovery and development. Nevertheless, to date, no computational method for RNA-small molecule binding affinity prediction has been proposed. The prediction of RNA-small molecule binding affinity remains a significant challenge. The development of a computational model is deemed essential to effectively extract relevant features and predict RNA-small molecule binding affinity accurately. Results In this study, we introduced RLaffinity, a novel deep learning model designed for the prediction of RNA-small molecule binding affinity based on 3D structures. RLaffinity integrated information from RNA pockets and small molecules, utilizing a 3D convolutional neural network (3D-CNN) coupled with a contrastive learning-based self-supervised pre-training model. To the best of our knowledge, RLaffinity was the first computational method for the prediction of RNA-small molecule binding affinity. Our experimental results exhibited RLaffinity's superior performance compared to baseline methods, revealing by all metrics. The efficacy of RLaffinity underscores the capability of 3D-CNN to accurately extract both global pocket information and local neighbor nucleotide information within RNAs. Notably, the integration of a self-supervised pre-training model significantly enhanced predictive performance. Ultimately, RLaffinity was also proved as a potential tool for RNA-targeted drugs virtual screening. Availability https://github.com/SaisaiSun/RLaffinity Supplementary information Supplementary data are available at Bioinformatics online.

RNAmigos2: Fast and accurate structure-based RNA virtual screening with semi-supervised graph learning and large-scale docking data

RNA-ligand interaction scoring via data perturbation and augmentation modeling

ParaVS: A Simple, Fast, Efficient and Flexible Graph Neural Network Framework for Structure-Based Virtual Screening

Contrastive pre-training and 3D convolution neural network for RNA and small molecule binding affinity prediction

NMR and SPR Fragment-Based Screening Can Produce Novel High Affinity Small Molecule Hits Against Structured RNAs

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Docking to RNA via Root-Mean-Square-Deviation-Driven Energy Minimization with Flexible Ligands and Flexible Targets

Diverse Database and Machine Learning Model to Narrow the Generalization Gap in RNA Structure Prediction

Improved Scaffold Hopping in Ligand-based Virtual Screening Using Neural Representation Learning

Deep Surrogate Docking: Accelerating Automated Drug Discovery with Graph Neural Networks

RNAvigate: efficient exploration of RNA chemical probing datasets

An artificial intelligence accelerated virtual screening platform for drug discovery

Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA

AnnapuRNA: A scoring function for predicting RNA-small molecule binding poses

Reliable method for predicting the binding affinity of RNA-small molecule interactions using machine learning

Interpretable RNA Foundation Model from Unannotated Data for Highly Accurate RNA Structure and Function Predictions

Improving Structure-Based Virtual Screening with Ensemble Docking and Machine Learning

Docking-based Virtual Screening for the Discovery of RNA-targeting Molecules: Identification of Selective Riboswitch Binding Ligands

Pose prediction accuracy in ligand docking to RNA

Fine tuning for success in structure-based virtual screening

Boosting Docking-Based Virtual Screening with Deep Learning